Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2010 by Chinese Academy of Medical Sciences.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Hoffmann-La Roche
Information provided by:
Chinese Academy of Medical Sciences
ClinicalTrials.gov Identifier:
NCT01126138
First received: May 18, 2010
Last updated: May 3, 2011
Last verified: May 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2015
  Estimated Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)
Publications: